New Strategy Intercepts Pancreatic Cancer by Eliminating Microscopic Lesions Before They Become Cancer Penn Medicine News The latest research at Penn Medicine, led by Drs. Minh Than, Ben Stanger and Robert Vonderheide focuses on targeting the earliest, pre-cancerous changes in the pancreas before the cells developed into pancreatic cancer. Latest News Breast Cancer Caused by Genetic Mutation Gets First Approved Treatment Through FDA Approval of Olaparib Philadelphia Inquirer News | January 2018 Expert Discusses Promise of Olaparib/Durvalumab Combo in BRCA+ Breast Cancer Targeted Oncology News | January 2018 Individual Knowledge Is Power in Addressing BRCA Gene Mutations Cure Magazine News | January 2018 Phil Basser Celebrates 100 Years with the Eagles Fox News News | January 2018 Olaparib/Durvalumab Combo Effective for BRCA-mutant Breast Cancer OncLive News | December 2017 Can Telomere Length Reveal How Well You’re Aging? Good Morning America News | November 2017 For Cancer Survivor, the Bell Tolls Loudly Bloomberg News | November 2017 Direct-to-Consumer Testing for Hereditary Cancers ‘Most Helpful’ when Integrated with Established Health Care Practice Healio News | October 2017 A Pill Might Control Pancreatic Cancer, Even If It Doesn't Cure It Forbes News | September 2017 Why the Breast Cancer Gene You May Never Have Heard of Could Matter Philadelphia Inquirer News | September 2017 Ethical Dilemmas Arise from Genetic Testing for Cancer Cure Magazine News | June 2017 Hope and Hype Around Cancer Immunotherapy CNN News | June 2017 Penn Effort to Expand Trials of Olaparib Leads to New Treatment Options for Patients with Advanced BRCA-Related Breast Cancer Penn Medicine News News | June 2017 Blackstone's Gray Gives $21 Million to Hit Cancer Close to Home Bloomberg News | May 2017 Ask the Experts: How to Talk About Family Medical History at Thanksgiving Philadelphia Inquirer News | November 2016 In the War Against Cancer, Modesty is Not an Ally Toronto Star News | November 2016 'In Our Genes' Event Raises Research Funds, Builds Community for Those at Increased Risk of Breast and Ovarian Cancers Cure Magazine News | October 2016 'Unzip Your Genes' benefit raises awareness about cancers linked to BRCA gene ABC7 News | November 2015 Pagination First page« First Previous page‹‹ … Page10 Page11 Page12 Page13 Page14 Page15 Page16 Current page17 Page18 Next page›› Last pageLast »
New Strategy Intercepts Pancreatic Cancer by Eliminating Microscopic Lesions Before They Become Cancer Penn Medicine News The latest research at Penn Medicine, led by Drs. Minh Than, Ben Stanger and Robert Vonderheide focuses on targeting the earliest, pre-cancerous changes in the pancreas before the cells developed into pancreatic cancer.
Breast Cancer Caused by Genetic Mutation Gets First Approved Treatment Through FDA Approval of Olaparib Philadelphia Inquirer News | January 2018
Expert Discusses Promise of Olaparib/Durvalumab Combo in BRCA+ Breast Cancer Targeted Oncology News | January 2018
Direct-to-Consumer Testing for Hereditary Cancers ‘Most Helpful’ when Integrated with Established Health Care Practice Healio News | October 2017
Why the Breast Cancer Gene You May Never Have Heard of Could Matter Philadelphia Inquirer News | September 2017
Penn Effort to Expand Trials of Olaparib Leads to New Treatment Options for Patients with Advanced BRCA-Related Breast Cancer Penn Medicine News News | June 2017
Ask the Experts: How to Talk About Family Medical History at Thanksgiving Philadelphia Inquirer News | November 2016
'In Our Genes' Event Raises Research Funds, Builds Community for Those at Increased Risk of Breast and Ovarian Cancers Cure Magazine News | October 2016
'Unzip Your Genes' benefit raises awareness about cancers linked to BRCA gene ABC7 News | November 2015
